In a case-control study involving 218 individuals, the combined analysis of IKZF1 and BCAT1 demonstrated a diagnostic sensitivity of 77% for CRC detection, with detection rates of 50% and 68% for stages I and II, respectively. The gene discussed is IKZF1; the disease is colorectal carcinoma.